Poniard Pharmaceuticals, Inc. Stock OTC Markets

Stocks

PARDP

US7324492021

Pharmaceuticals

OTC Markets Traded
Delayed 5-day change 1st Jan Change
- USD -.--% Intraday chart for Poniard Pharmaceuticals, Inc. -.--% -

Valuation: Poniard Pharmaceuticals, Inc.

Market Cap 3.19M 2.82M 2.67M 2.42M 4.53M 306M 4.58M 31.99M 12.33M 156M 11.99M 11.73M 504M P/E 2009
-1.4x
P/E 2010 -0.79x
Enterprise Value 437K 386K 365K 331K 621K 41.97M 627K 4.38M 1.69M 21.43M 1.64M 1.61M 68.96M EV / Sales 2009
-
EV / Sales 2010 -
Free-Float
2.5%
Yield 2009 *
-
Yield 2010 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 149
+3.13%+11.45%+703.24%+96.98% 81.23B
-0.23%-6.64%+33.84%-8.80% 74.94B
+1.05%+2.78%-7.05%-25.22% 60.9B
-1.07%-0.43%-10.19%+32.27% 47.22B
-0.63%-2.98%-12.64%+163.75% 44.68B
-0.71%+0.76%+63.93%-11.65% 33.55B
-1.30%-2.94%+46.86%+113.26% 24.97B
+0.48%0.00%+53.28%+95.55% 15.17B
-0.96%-4.71%+26.96%+150.17% 12.9B
Average -0.49%-0.91%+99.80%+67.37% 43.95B
Weighted average by Cap. -0.55%+0.35%+158.40%+51.44%

Financials

2009 2010
Net sales - -
Net income -45.72M -40.34M -38.17M -34.62M -64.9M -4.39B -65.54M -458M -176M -2.24B -172M -168M -7.21B -30.05M -26.52M -25.09M -22.76M -42.66M -2.88B -43.08M -301M -116M -1.47B -113M -110M -4.74B
Net Debt -23.12M -20.4M -19.3M -17.51M -32.82M -2.22B -33.15M -232M -89.25M -1.13B -86.81M -84.92M -3.65B -2.76M -2.43M -2.3M -2.09M -3.91M -264M -3.95M -27.61M -10.64M -135M -10.35M -10.12M -435M
Logo Poniard Pharmaceuticals, Inc.
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.
Employees
-